New Study Links Paxil to Twice as Many Birth Defects as Other Antidepressants The FDA and the drug company GlaxoSmithKline are alerting doctors about a new study on major birth defects seen in babies born to women who took the antidepressant Paxil during the first trimester of pregnancy.”Healthcare professionals are advised to carefully weigh the potential [...]
Continue reading...
Wednesday, July 2, 2008
0 Comments